Ordering
Available Variants100 mg
CHA.34698-100mg
Price
€52.98
Available – Dispatch in 14 days
500 mg
CHA.34698-500mg
Price
€182.40
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
100 mg | CHA.34698-100mg | €52.98 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
500 mg | CHA.34698-500mg | €182.40 |
96%
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C5H9N5 |
|---|---|
| CAS Number | 33878-70-5 |
| Molecular Weight | 139.16 |
| NACRES | NA.22 |
| PubChem Substance ID | 329760905 |
| UNSPSC Code | 12352005 |
| MDL number | MFCD10000886 |
Safety Information Handling visibility
| pictograms |
GHS06
 GHS06
|
|---|---|
| signalword | Danger |
| hcodes | H301,H315,H319,H335 |
| pcodes | P301 + P310 + P330 - P302 + P352 - P305 + P351 + P338 |
| Hazard Classifications | Acute Tox. 3 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
| target_organs | Respiratory system |
| Storage Class | 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges |
Technical Overview & Applications Use-case context
(S)-(–)-5-(2-Pyrrolidinyl)-1H-tetrazole, with a CAS number of 33878-70-5, is a synthetic compound that has garnered significant attention in the realm of pharmaceutical and chemical research. This tetrazole derivative exhibits unique properties, rendering it a valuable intermediate in the synthesis of various biologically active molecules. The compounds structure, comprising a pyrrolidinyl moiety attached to a tetrazole ring, confers distinct chemical and physical characteristics. As a result, (S)-(–)-5-(2-Pyrrolidinyl)-1H-tetrazole has been employed in the development of novel therapeutic agents, including those targeting neurological disorders and infectious diseases. Further research into the properties and applications of this compound is warranted to fully exploit its potential in the fields of medicine and chemistry. Its synthesis and characterization have been extensively studied, providing a foundation for future investigations.
